Dermatology Pipeline Highlights Database – 2016, provides most up-to-date information on key pipeline molecules in the global Dermatology market. It covers emerging therapies for Dermatology disorders in active clinical development stages including early and late stage clinical trials. Key indications covered in this report include Impetigo, Atopic Dermatitis, Psoriasis, Erythema multiforme, Alopecia Areata, Acne, and Rosacea. The pipeline data is presented in an excel dashboard with filtering options. The pipeline data presented in this report helps executives for tracking competition, identifying partners, evaluating opportunities, formulating business development strategies, and executing in-licensing and out-licensing deals.
By Indication: The report presents pipeline by Dermatology indications. Key indications covered in this report include Impetigo, Atopic Dermatitis, Psoriasis, Erythema multiforme, Alopecia Areata, Acne, and Rosacea.
By Clinical Trial Stages: The report provides Dermatology pipeline molecules by clinical trial stages including both early and late stage development - phase 3 clinical trials, phase 2 clinical trials, phase 1 clinical trials, preclinical research, and discovery stage.
ByDrug Mechanism Classes: The report provides Dermatology pipeline molecules by their dominant drug mechanism class. This helps executives categorize molecules based on their drug class and also assess the strengths and weaknesses of compounds.
By Company: The report provides Dermatology pipeline molecules by the developing company and the partnered company.
SUMMARY: - Dermatology Pipeline by Indication - Dermatology Pipeline by Clinical Trial Phase - Dermatology Pipeline by Drug Mechanism Classes - Dermatology Pipeline by Company
Our reports have been used by over 10K customers, including:
The global immunofluorescence assays market is projected to reach USD 3.5 billion by 2026 from USD 2.6 billion in 2021, at a CAGR of 6.0% during the forecast period. The growth in this market is primarily attributed to the increasing prevalence of chronic diseases and rising R&D spending & healthcare expenditure. Emerging markets are expected...
Anatomic Pathology Market Report Overview Anatomic Pathology market size outlook report provides comprehensive coverage of market landscape including strategic growth areas, unique insights, and major trends across Anatomic Pathology market types and applications. It is a focused study on Anatomic Pathology market space including global...
Pathology Devices Market Report Overview Pathology Devices market size outlook report provides comprehensive coverage of market landscape including strategic growth areas, unique insights, and major trends across Pathology Devices market types and applications. It is a focused study on Pathology Devices market space including global and...
Digital Pathology Market Size, Share & Trends Analysis Report By Product (Software, Device), By Application (Drug Discovery & Development, Academic Research), By End-use, By Region, And Segment Forecasts, 2021 - 2028 Digital Pathology Market Growth & Trends The global digital pathology market...
The global organoids market is expected to reach US$ 3,420.40 million by 2027 from US$ 689.47 million in 2019. The market is estimated to grow at a CAGR of 22.1% from 2020 to 2027. Increasing demand for tumor modelling and biobanking, rising adoption of personalized drugs, and growing focus on developing alternatives for animal testing...
The current practice of medical education and methods of performing surgery and therapy suffer from limitations such as scarcity of subjects to practice on, suboptimal surgical precision, and therapy-related issues including medication misuse and ineffectiveness of the drugs to treat the conditions. Moreover, the outbreak of COVID-19 pandemic...
200 pages •
By The Business Research Company
• Dec 2020
Major players in the anatomical pathology equipment and consumables market are Epridea, F. Hoffmann-La Roche Ltd., Danaher Corporation, Thermo Fisher Scientific, Sakura Finetek, Agilent Technologies, Danaher Corporation, Bio SB, BioGenex Laboratories, and Quest Diagnostics Incorporated. The global anatomic pathology equipment and consumables...
An organ-on-a-chip is a microfluidic cell culture device that contains continuously perfused chambers. This chip develops a narrow channel for the blood and airflow in organs, such as the lung, gut, liver, heart, and other organs. Such devices produce multiple levels of tissue and organ functionalities, which are not feasible using conventional...
KEY FINDINGS The global disposable patient positioning products market is anticipated to register a CAGR of 3.21%, during the forecast years of 2021 to 2028. The primary market growth drivers include the growing volume of surgeries, the rise in the geriatric population, and the surging investments across the healthcare...
17 pages •
By Euromonitor International
• Jan 2021
Natural increase will be the sole driver of population expansion in the Dominican Republic up to 2040. While ageing will be a key trend, with rapid growth in the elderly and a decline in the younger age groups, the country will remain relatively young as birth rates remain comparatively high. Nevertheless, as population composition alters...
Net Migration Rate
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.